Andreas Unterberg Selected Research

Andreas Unterberg Research Topics

Disease

55	Neoplasms (Cancer) 12/2022 - 03/2006
36	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 03/2006
32	Glioma (Gliomas) 12/2022 - 04/2006
13	Astrocytoma (Pilocytic Astrocytoma) 12/2022 - 10/2009
9	Brain Neoplasms (Brain Tumor) 07/2021 - 06/2010
8	Meningioma (Meningiomas) 12/2021 - 03/2008
6	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022 - 01/2012
6	Neuralgia (Stump Neuralgia) 01/2022 - 03/2006
4	Oligodendroglioma 12/2022 - 10/2009
3	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 04/2022 - 01/2013
3	Intracranial Hypertension 01/2022 - 01/2007
3	Contusions 12/2021 - 01/2020
3	Pain (Aches) 08/2021 - 10/2017
3	Hematoma 09/2015 - 08/2000
3	Stroke (Strokes) 10/2014 - 06/2010
2	Spinal Cord Injuries (Spinal Cord Injury) 01/2022 - 01/2020
2	Spinal Cord Compression 12/2021 - 01/2020
2	Gliosis 01/2021 - 01/2020
2	Hydrocephalus (Hydrocephaly) 12/2020 - 11/2020
2	Wounds and Injuries (Trauma) 01/2020 - 09/2015
2	Necrosis 01/2020 - 01/2019
2	Brain Injuries (Brain Injury) 12/2016 - 01/2013
2	Medulloblastoma 01/2016 - 08/2012
2	Thromboembolism 02/2011 - 06/2003
2	Infarction (Infarctions) 02/2011 - 01/2007
1	Diabetes Insipidus 08/2022
1	Mucormycosis 06/2022
1	Abscess 06/2022
1	COVID-19 06/2022
1	Brain Ischemia (Cerebral Ischemia) 04/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 11/2021

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 12/2022 - 06/2010
12	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 10/2020 - 10/2009
7	Biomarkers (Surrogate Marker)IBA 12/2022 - 09/2015
7	Messenger RNA (mRNA)IBA 11/2021 - 12/2011
6	Protons (Proton)IBA 07/2021 - 09/2010
6	RNA (Ribonucleic Acid)IBA 12/2020 - 08/2012
6	AntigensIBA 01/2018 - 01/2008
6	ErbB Receptors (EGF Receptor)IBA 07/2009 - 04/2006
5	Pharmaceutical PreparationsIBA 11/2021 - 05/2010
5	Temozolomide (Temodar)FDA LinkGeneric 08/2021 - 09/2010
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 06/2015
5	Oxygen (Dioxygen)IBA 01/2020 - 12/2010
5	Tretinoin (Retinoic Acid)FDA LinkGeneric 04/2016 - 05/2010
5	Tyrosine Kinase InhibitorsIBA 08/2009 - 04/2006
4	APTIBA 09/2019 - 06/2018
4	CarbonIBA 05/2016 - 09/2010
4	Biological ProductsIBA 10/2014 - 11/2008
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2009 - 04/2006
3	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2013
3	MethyltransferasesIBA 01/2019 - 01/2018
3	Peptides (Polypeptides)IBA 01/2018 - 06/2010
3	EnzymesIBA 01/2017 - 03/2006
2	Phosphotransferases (Kinase)IBA 11/2021 - 01/2018
2	MicroRNAs (MicroRNA)IBA 03/2021 - 06/2015
2	KinesinsIBA 01/2021 - 04/2019
2	4-amino-tetrahydrobiopterinIBA 12/2020 - 01/2020
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2020 - 10/2016
2	AmidesIBA 09/2019 - 11/2018
2	EpitopesIBA 01/2018 - 12/2011
2	LigandsIBA 12/2017 - 04/2006
2	Codon (Codons)IBA 01/2017 - 08/2012
2	RetinoidsIBA 10/2015 - 05/2011
2	Carrier Proteins (Binding Protein)IBA 10/2012 - 05/2011
2	CytokinesIBA 07/2011 - 05/2006
2	NestinIBA 03/2011 - 02/2011
2	IonsIBA 11/2010 - 10/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2008 - 05/2006
1	VimentinIBA 12/2022
1	Formaldehyde (Formol)FDA Link 12/2022
1	ParaffinIBA 12/2022
1	SteroidsIBA 06/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 06/2022
1	Nimodipine (Modus)FDA LinkGeneric 04/2022
1	Interleukin-4 (Interleukin 4)IBA 01/2022
1	salicylhydroxamic acid (SHAM)IBA 12/2021
1	Bromodeoxyuridine (BrdU)IBA 11/2021
1	tyrosine receptor (receptor, tyrosine)IBA 11/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2021
1	Gentian Violet (Violet, Crystal)FDA Link 11/2021
1	ponatinibIBA 11/2021

Therapy/Procedure

32	Therapeutics 06/2022 - 05/2006
11	Radiotherapy 03/2021 - 03/2010
7	Drug Therapy (Chemotherapy) 01/2021 - 10/2010
5	Spinal Cord Stimulation 01/2022 - 07/2006
5	Heavy Ion Radiotherapy 11/2018 - 03/2010
4	Decompressive Craniectomy 01/2022 - 01/2014
4	Surgical Instruments (Clip) 12/2021 - 06/2003
4	Immunotherapy 10/2020 - 06/2010
3	Deep Brain Stimulation 10/2019 - 10/2017
3	Conservative Treatment 09/2015 - 01/2007
3	Critical Care (Surgical Intensive Care) 01/2013 - 06/2010
2	Reoperation 08/2022 - 12/2020
2	Craniotomy 01/2022 - 01/2022
2	Transplantation 01/2022 - 01/2020
2	Cell Transplantation 12/2021 - 01/2020
2	Aftercare (After-Treatment) 07/2021 - 12/2017
2	Re-Irradiation 11/2018 - 10/2010
2	Electrodes (Electrode) 08/2018 - 03/2006
2	Chemoradiotherapy 01/2016 - 09/2010